Gynaecological cancer

Please see below all current gynaecological cancer clinical trials of the Central Coast Cancer Centre.

 

Name: ORCCYD

A Randomized, Open-Label Study Comparing the Combination of YONDELIS® and DOXIL®/CAELYX® With DOXIL®/CAELYX® Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer.

Protocol Number: ET743-OVC-3
Principal Investigator: Dr Susan Tiley
Study Coordinator: Leonie Kelly
Status: Recruiting
Condition: Gynaecological Cancer
External page link More information about ORCCYD

Name: VELIA

A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel With or Without Concurrent and Continuation Maintenance Veliparib (PARP inhibitor) in Subjects with Previously Untreated Stages III or IV High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

Protocol Number: M13-694
Principal Investigator: Dr Susan Tiley
Study Coordinator: Leonie Kelly
Status: Recruiting
Condition: Gynaecological Cancer
External page link More information about Ovarian Cancer Study

More information

For more information about medical oncology clinical trials please contact the Nurse Unit Manager on 02 4320 3940 or see:

Internal page Research and Clinical Trials